Instil Bio (TIL) Research & Development (2020 - 2026)
Instil Bio (TIL) posted quarterly Research & Development of $669000.0 for Q1 2026, down 87.54% year-over-year from $5.4 million in Q1 2025, and down 80.87% quarter-over-quarter from $3.5 million in Q4 2025.
Instil Bio (TIL) Research & Development (2020 - 2026) Analysis & Trends
Instil Bio's Research & Development history runs 7 years deep, the most recent figure standing at $669000.0 for Q1 2026.
- In Q1 2026, Research & Development fell 87.54% year-over-year to $669000.0; the TTM figure through Mar 2026 stood at $20.0 million (up 101.31% YoY), while the FY2025 annual figure was $24.7 million, up 108.97% from the prior year.
- Research & Development for Q1 2026 stood at $669000.0, down from $3.5 million in the prior quarter.
- The five-year high for Research & Development was $41.5 million in Q2 2022, with the low at $562000.0 in Q3 2024.
- The 5-year median for Research & Development is $7.3 million (2024), against an average of $12.8 million.
- The sharpest annual moves came in 2024 and 2025: Research & Development sank 93.38% in 2024, then surged 1524.02% in 2025.
- Instil Bio's Research & Development stood at $20.7 million in 2022, then slumped by 90.43% to $2.0 million in 2023, then tumbled by 44.58% to $1.1 million in 2024, then surged by 218.2% to $3.5 million in 2025, then sank by 80.87% to $669000.0 in 2026.
- Business Quant data shows TIL's Research & Development at $669000.0 in Q1 2026, $3.5 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 270,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270,000.00 |
| Mar 31, 2026 | 669,000.00 |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 562,000.00 |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 8.46 Mn |
| Mar 31, 2023 | 20.67 Mn |
| Dec 31, 2022 | 20.72 Mn |
| Sep 30, 2022 | 39.66 Mn |
| Jun 30, 2022 | 41.50 Mn |
| Mar 31, 2022 | 39.17 Mn |
| Dec 31, 2021 | 42.58 Mn |
| Sep 30, 2021 | 29.06 Mn |